CLINICAL_TRIALS
trial_result
· 2016-01-20
Clinical Trial Update: Therapy of Early Chronic Phase CML With Gleevec [Phase 2]
Summary
Phase 2 trial evaluating Gleevec (imatinib) in early chronic phase chronic myeloid leukemia; the study has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia, Myeloid, Chronic-Phase | Phase 2 | Status: COMPLETED